Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs.

Nicole M Gastala,Peter Wingrove,Anne Gaglioti,Stephen Petterson,Andrew Bazemore

HEALTH AFFAIRS（2016）

引用 8|浏览4

暂无评分

摘要

Prescription drugs are a major source of US health care expenditure. "Me too" brandname medications contribute to the cost of drugs, which is substantial for consumers. In 2013 patient copayments averaged 10.5 times more for two commonly prescribed brandname medications versus generic therapeutic alternatives.

查看译文

关键词

Consumer Issues,Health Professions Education,Health Spending,Medicare,Pharmaceuticals

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要